Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2014
02/27/2014US20140057933 Opioids for the treatment of the chronic obstructive pulmonary disease (copd)
02/27/2014US20140057924 Bivalent inhibitors of iap proteins and therapeutic methods using the same
02/27/2014US20140057923 Treating Sexual Desire Disorders with Flibanserin
02/27/2014US20140057922 Trazodone and trazodone hydrochloride in purified form
02/27/2014US20140057917 Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side Effects
02/27/2014US20140057915 Kinase inhibitors
02/27/2014US20140057914 Heterocyclic modulators of hif activity for treatment of disease
02/27/2014US20140057910 Heterocyclic aspartyl protease inhibitors
02/27/2014US20140057905 Cancer diagnostics, therapeutics, and drug discovery associated with macropinocytosis
02/27/2014US20140057904 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathway
02/27/2014US20140057902 Diazepinone derivatives
02/27/2014US20140057901 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
02/27/2014US20140057898 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis
02/27/2014US20140057897 Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias
02/27/2014US20140057896 Pyridone and aza-pyridone compounds and methods of use
02/27/2014US20140057890 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
02/27/2014US20140057889 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
02/27/2014US20140057888 Compounds and their use
02/27/2014US20140057885 Methods of treating epilepsy or status epilepticus
02/27/2014US20140057884 Pharmaceutical composition for preventing or treating liver cancer comprising stigmasterol and 5 beta-hydroxysitostanol isolated from navicula incerta
02/27/2014US20140057883 Treatment of crohn's disease with laquinimod
02/27/2014US20140057882 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
02/27/2014US20140057881 Composition for the Treatment of Skin Conditions
02/27/2014US20140057880 Antcin derivatives in combination with anti-cancer drugs in the treatment and/or prevention of tumors
02/27/2014US20140057879 Co-crystals of tramadol and coxibs
02/27/2014US20140057875 Crystallization method and bioavailability
02/27/2014US20140057873 Nitric oxide releasing amino acid ester compound, composition and method of use
02/27/2014US20140057872 Dosage forms of risedronate
02/27/2014US20140057871 Cyclic amide derivative
02/27/2014US20140057870 Bicyclic triazole and pyrazole lactams as allosteric modulators of mglur5 receptors
02/27/2014US20140057869 Novel Pharmaceutical Agents Containing Carbohydrate Moieties And Methods Of Their Preparation And Use
02/27/2014US20140057868 Catalytic hydrogenolysis of a composition of a mixture of oligosaccharide precursors and uses thereof
02/27/2014US20140057867 Compositions and Methods of Aloe Polysaccharides
02/27/2014US20140057866 Phosphoramidate derivatives of 5 - fluoro - 2` - deoxyuridine for use in the treatment of cancer
02/27/2014US20140057865 Analysis of nodes in cellular pathways
02/27/2014US20140057864 Compositions and methods for treating or preventing a retrovirus infection
02/27/2014US20140057863 Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
02/27/2014US20140057862 Formulations of histone deacetylase inhibitor and uses therof
02/27/2014US20140057861 Compositions and methods for treating or preventing anthracycline induced cardiotoxicity
02/27/2014US20140057860 Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases and method of manufacturing the same
02/27/2014US20140057859 Hyaluronate Compositions
02/27/2014US20140057852 Treatment of Cancers with A-8R Peptide
02/27/2014US20140057851 Anti-Angiogenic Gene Therapy With Soluble VEGF Receptors -1, -2 and -3 Together With Paclitaxel Prolongs Survival Of Mice With Human Ovarian Carcinoma
02/27/2014US20140057845 Composition for treating, improving, or preventing pain
02/27/2014US20140057844 Chemical entities and therapeutic uses thereof
02/27/2014US20140057842 Compositions and methods for cell homing and adipogenesis
02/27/2014US20140057839 Formulations and methods for weight loss and body contouring
02/27/2014US20140057837 Methods and compositions for the "browning" of white fat
02/27/2014US20140057835 Methods for treating hcv
02/27/2014US20140057249 Jak/stat inhibitors and mapk/erk inhibitors for rsv infection
02/27/2014US20140057007 Food, particularly a beverage for human consumption
02/27/2014US20140057006 Pharmaceutical Compositions for the Treatment of Warts
02/27/2014US20140057001 Methods of decreasing sebum production in the skin
02/27/2014US20140056999 Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom
02/27/2014US20140056998 System and method for diagnosis and treatment of neuropsychiatric disorders
02/27/2014US20140056997 Use of low molecular weight amino alcohols in ophthalmic compositions
02/27/2014US20140056996 Antitumoral combination comprising cabazitaxel and cisplatin
02/27/2014US20140056995 Use of compounds isolated from euphorbia neriifolia for treating cancer and/or thrombocytopenia
02/27/2014US20140056994 Fixed-Dose Association of Phytate and Zinc
02/27/2014US20140056993 Composition comprising antimicrobial metal ions and a quaternary cationic surfactant
02/27/2014US20140056990 Composition for the treatment of migraine headaches and methods thereof
02/27/2014US20140056988 Novel Inhibitors of Arachidonic Acid Formation
02/27/2014US20140056987 Compositions comprising extracts or fractions derived from annona squamosa for the prevention, treatment or control of inflammatory and metabolic disorders
02/27/2014US20140056986 Methods of treating bladder cancer
02/27/2014US20140056985 Method for production of particles of pharmaceutical substances and the use thereof
02/27/2014US20140056983 Food additive for ruminants based on eugenol and cinnamaldehyde
02/27/2014US20140056981 Method for producing drug-loaded polymeric nanoparticles by polymerization in presence of drugs
02/27/2014US20140056979 Controlled Release Pharmaceutical Dosage Forms
02/27/2014US20140056978 Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
02/27/2014US20140056977 Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate and polymorphs thereof
02/27/2014US20140056975 Pharmaceutical Composition
02/27/2014US20140056974 Spontaneously Dispersible N-Benzoyl Staurosporine Compositions
02/27/2014US20140056973 Oral Dosage Forms Having a High Loading of a Methyl Hydrogen Fumarate Prodrug
02/27/2014US20140056971 Delivery of ibuprofen and other compounds
02/27/2014US20140056970 Efficient method for loading amphoteric liposomes with nucleic acid active substances
02/27/2014US20140056968 Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it
02/27/2014US20140056965 Method and system for treating depression or epilepsy
02/27/2014US20140056964 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
02/27/2014US20140056963 Extended production of nitric oxide from a microencapsulated nitrite salt and an aqueous acidified gel
02/27/2014US20140056962 Drug delivery system
02/27/2014US20140056961 Platinum-catalyzed intravaginal rings
02/27/2014US20140056957 Extended production of nitric oxide from microencapsulated chemical reactants
02/27/2014US20140056951 Methods and compositions for treating biofilms
02/27/2014US20140056929 IMMUNOMODULATION BY CONTROLLING INTERFERON-GAMMA LEVELS WITH THE LONG NON-CODING RNA NeST
02/27/2014US20140056928 Novel compounds
02/27/2014US20140056927 Lipotheichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
02/27/2014US20140056926 Complex in which anti-cotinine antibody is bound to conjugate of cotinine and binding substance, and use thereof
02/27/2014US20140056922 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
02/27/2014US20140056919 Methods and compositions for treating inflammatory conditions
02/27/2014US20140056916 Aldosterone induced vascular elastin production
02/27/2014US20140056910 Therapeutic agent for cancer having reduced sensitivity to molecular target drug and pharmaceutical composition for enhancing sensitivity to molecular target drug
02/27/2014US20140056909 Treating cancer
02/27/2014US20140056898 Combination therapies comprising anti-erbb3 agents
02/27/2014US20140056889 Compositions and method for treating autoimmune diseases
02/27/2014US20140056885 Subcutaneously administered anti-il-6 receptor antibody
02/27/2014US20140056880 Triazole compounds as ksp inhibitors
02/27/2014US20140056863 Nutritional compositions having alpha-hica and eicosapentaenoic acid
02/27/2014US20140056862 Nutritional compositions having alpha-hica and alpha-ketoglutarate
02/27/2014US20140056849 Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use
02/27/2014US20140056848 Method for the Treatment of Multiple Sclerosis
1 ... 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 ... 7860